Mission
IHSI provides data that empowers political decision-makers and payer organisation negotiators to drive for better pricing in medicinal products. IHSI data enables healthcare systems to prepare for disruptive technologies through data insights that deliver the leverage required to confidently assess new products coming to market.
Team
As an independent legal entity, IHSI is composed of three organisational bodies. Each member state provides a representative to the Executive Committee, the key decision-making body. From this, the members of the Board of Directors are elected who, together with the Secretariat, oversee the IHSI’s operational management.
Get involved
As a member-state driven organisation, participating countries retain control over the functioning and operations of the initiative.
There are several ways to participate in IHSI. Countries currently not in the initiative may apply for Full Membership, while organisations from countries within the initiative may apply for Affiliate Membership. Not-for-profit organisations seeking to participate in IHSI activities may apply as Joined Members.
* — Spent by IHSI member states on pharmaceutical products. Data based on OECD data for the year 2017
** — assumption that with IHSI data-driven negotiations, prices for new pharmaceutical products can be reduced on average by minimum 1%.
IHSI has elected the 5th member of the Board of Directors
IHSI’s Executive Committee has met for the second face-to-face meeting this year on 22-23 November 2023. We are proud to [...]
IHSI re-appoints Prof. Diana Delnoij as Chair of the Board and Executive Committee
In a special meeting in Copenhagen on 16 November 2022, the IHSI Executive Committee (EXCO) unanimously re-appointed Prof. Diana Delnoij [...]